查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032615

皮膚科藥物市場：按皮膚疾病、給藥途徑、分銷管道和地區分類（2026-2034 年）

Dermatological Drugs Market by Dermatological Diseases, Route of Administration, Distribution Channel, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球皮膚科藥品市場規模達282億美元。展望未來，IMARC Group預測，該市場從2026年到2034年將以7.96%的複合年成長率成長，到2034年達到574億美元。皮膚疾病盛行率上升、對藥用化妝品（功能性化妝品）的需求增加以及人們皮膚健康意識的提高是推動市場成長的主要因素。

皮膚科藥物是用於治療各種皮膚疾病的藥物，包括痤瘡、銀屑病、酒糟、酒渣鼻、皮膚癌、真菌感染疾病以及其他影響皮膚、毛髮和指甲的疾病。根據所治療的皮膚疾病類型，這些藥物可透過外用、口服或注射給藥。外用皮膚科藥物，如乳膏、軟膏、凝膠和噴霧劑，直接塗抹於皮膚上。它們最常用於治療局部皮膚疾病，例如痤瘡和濕疹。另一方面，全身性皮膚科藥物則以口服或注射給藥，作用於皮膚疾病的根本原因。這些藥物通常用於治療嚴重的或廣泛的皮膚疾病，例如銀屑病。這些產品兼具美容和藥理作用，旨在改善皮膚的整體健康和外觀。此外，由於皮膚科醫生和其他具有皮膚健康專業知識的醫療保健專業人員會開立皮膚科藥物，因此全球對皮膚科藥物的需求正在增加。

皮膚科藥物市場趨勢：

該市場的主要驅動力是銀屑病、濕疹、痤瘡、酒糟和皮膚癌等皮膚疾病的日益普遍。此外，老年人口的成長（他們更容易患上這些疾病）也是推動市場成長的另一個主要因素。同時，具有藥用功效、旨在改善皮膚整體健康和外觀的化妝品（藥藥用化妝品品）也越來越受歡迎。這一點，加上公眾對保持皮膚健康重要性的認知不斷提高，正在積極影響市場成長。如今，越來越多的患者尋求皮膚疾病的治療，導致對皮膚科藥物的整體需求增加。此外，經皮貼片、奈米技術和微針等藥物傳遞系統的各種技術進步也推動了皮膚科藥物市場的成長。這些新型藥物遞送系統提高了藥物療效並改善了患者的用藥依從性。此外，消費者可支配收入的增加、非處方藥（OTC）的日益普及以及對現有治療方案的認知不斷提高，也為全球市場前景的良好發展做出了貢獻。

本報告解答的主要問題

  • 迄今為止，全球皮膚科藥品市場的發展趨勢是什麼？您預計未來幾年這些趨勢將如何演變？
  • 全球皮膚科藥品市場的促進因素、限制因素和機會是什麼？
  • 各種促進因素​​、阻礙因素和機會如何影響全球皮膚科藥物市場？
  • 主要區域市場有哪些？
  • 哪個國家對皮膚科藥品的需求市場最具吸引力？
  • 依皮膚病分類的市場區隔如何？
  • 在皮膚科藥物市場中，哪種皮膚疾病最受關注？
  • 依行政途徑分類的市場區隔如何？
  • 在皮膚科藥物市場中，哪一種給藥途徑最具吸引力？
  • 按分銷管道分類的市場區隔如何？
  • 在皮膚科藥品市場中，哪種通路最具吸引力？
  • 全球皮膚病藥物市場的競爭格局如何？
  • 全球皮膚病藥物市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球皮膚科藥物市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場細分：依皮膚病分類

  • 粉刺
  • 皮膚炎
  • 銀屑病
  • 皮膚癌
  • 其他

第7章 市場區隔：依給藥途徑

  • 口服
  • 腸外
  • 外用

第8章 市場區隔：依分銷通路分類

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章：促進、抑制與機遇

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • AbbVie Inc.
    • Amgen Inc.
    • Bausch Health Companies Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • GSK plc
    • LEO Pharma A/S（LEO Holding A/S）
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
Product Code: SR112026A7758

The global dermatological drugs market size reached USD 28.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 57.4 Billion by 2034, exhibiting a growth rate (CAGR) of 7.96% during 2026-2034. The rising prevalence of skin disorders, the increasing demand for cosmeceuticals, and the growing awareness among individuals about skin health represent some of the key factors driving the market.

Dermatological drugs are medications that are used to treat various skin conditions, including acne, psoriasis, eczema, rosacea, skin cancer, fungal infections, and other disorders affecting the skin, hair, and nails. These drugs can be applied topically, orally, or by injection, depending on the type of skin condition being treated. Topical dermatological drugs, including creams, ointments, gels, and sprays, are directly applied to the skin. They are most commonly used to treat localized skin conditions, such as acne or eczema. On the other hand, systemic dermatological drugs are taken orally or by injection and work by targeting the underlying cause of a skin condition. These drugs are often used to treat severe or widespread skin conditions, such as psoriasis. These products have both cosmetic and pharmaceutical properties, and they are designed to improve the overall health and appearance of the skin. Moreover, dermatological drugs are prescribed by dermatologists or other healthcare professionals with expertise in skin health, which is escalating their demand across the globe.

DERMATOLOGICAL DRUGS MARKET TRENDS:

The market is primarily driven by the increasing prevalence of skin disorders such as psoriasis, eczema, acne, rosacea, and skin cancer. In addition, the rising geriatric population that is more susceptible to such ailments represents another major growth-inducing factor. Besides this, individuals are widely adopting cosmeceuticals, which are cosmetic products with pharmaceutical properties to improve the overall health and appearance of the skin. This, coupled with the growing awareness among individuals about the importance of maintaining healthy skin, is positively influencing the market growth. Patients are now more aware of seeking treatment for skin conditions, leading to an increase in the overall demand for dermatological drugs. Moreover, various technological advancements in drug delivery systems, such as transdermal patches, nanotechnology, and microneedles, are driving the growth of the dermatological drugs market. These new drug delivery systems improve the efficacy of drugs and enhance patient compliance. Furthermore, the rising disposable incomes of consumers, the growing popularity of over the counter (OTC) drugs and the increasing awareness regarding the available treatment options are some of the other factors creating a favorable market outlook across the globe.

KEY MARKET SEGMENTATION:

Dermatological Diseases Insights:

  • Acne
  • Dermatitis
  • Psoriasis
  • Skin Cancer
  • Others

Route of Administration Insights:

  • Oral
  • Parenteral
  • Topical

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Insights:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for dermatological drugs. Some of the factors driving the North America dermatological drugs market included the growing prevalence of skin conditions, the rising awareness regarding appearance, and the escalating demand for cosmeceuticals.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global dermatological drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include AbbVie Inc., Amgen Inc., Bausch Health Companies Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GSK plc, LEO Pharma A/S (LEO Holding A/S), Novartis AG, Pfizer Inc., Sanofi S.A., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global dermatological drugs market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global dermatological drugs market?
  • What is the impact of each driver, restraint, and opportunity on the global dermatological drugs market?
  • What are the key regional markets?
  • Which countries represent the most attractive dermatological drugs market?
  • What is the breakup of the market based on dermatological diseases?
  • Which is the most attractive dermatological disease in the dermatological drugs market?
  • What is the breakup of the market based on the route of administration?
  • Which is the most attractive route of administration in the dermatological drugs market?
  • What is the breakup of the market based on distribution channel?
  • Which is the most attractive distribution channel in the dermatological drugs market?
  • What is the competitive structure of the global dermatological drugs market?
  • Who are the key players/companies in the global dermatological drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Dermatological Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Dermatological Diseases

  • 6.1 Acne
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Dermatitis
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Psoriasis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Skin Cancer
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parenteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Topical
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bausch Health Companies Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bristol-Myers Squibb Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eli Lilly and Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GSK plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 LEO Pharma A/S (LEO Holding A/S)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Novartis AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pfizer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sanofi S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Dermatological Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Dermatological Drugs Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Dermatological Drugs Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Dermatological Drugs Market: Breakup by Dermatological Diseases (in %), 2025
  • Figure 5: Global: Dermatological Drugs Market: Breakup by Route of Administration (in %), 2025
  • Figure 6: Global: Dermatological Drugs Market: Breakup by Distribution Channel (in %), 2025
  • Figure 7: Global: Dermatological Drugs Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Dermatological Drugs (Acne) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Dermatological Drugs (Acne) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Dermatological Drugs (Dermatitis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Dermatological Drugs (Dermatitis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Dermatological Drugs (Psoriasis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Dermatological Drugs (Psoriasis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Dermatological Drugs (Skin Cancer) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Dermatological Drugs (Skin Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Dermatological Drugs (Other Dermatological Diseases) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Dermatological Drugs (Other Dermatological Diseases) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Dermatological Drugs (Oral) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Dermatological Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Dermatological Drugs (Parenteral) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Dermatological Drugs (Parenteral) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Dermatological Drugs (Topical) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Dermatological Drugs (Topical) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Dermatological Drugs (Hospital Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Dermatological Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Dermatological Drugs (Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Dermatological Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Dermatological Drugs (Online Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Dermatological Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: North America: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: North America: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: United States: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: United States: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Canada: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Canada: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Asia-Pacific: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Asia-Pacific: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: China: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: China: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Japan: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Japan: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: India: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: India: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: South Korea: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: South Korea: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Australia: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Australia: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Indonesia: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Indonesia: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Others: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Others: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Europe: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Europe: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Germany: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Germany: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: France: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: France: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: United Kingdom: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: United Kingdom: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Italy: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Italy: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Spain: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Spain: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Russia: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Russia: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Latin America: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Latin America: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Brazil: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Brazil: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Mexico: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Mexico: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Others: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Others: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Middle East and Africa: Dermatological Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Middle East and Africa: Dermatological Drugs Market: Breakup by Country (in %), 2025
  • Figure 78: Middle East and Africa: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Global: Dermatological Drugs Industry: Drivers, Restraints, and Opportunities
  • Figure 80: Global: Dermatological Drugs Industry: Value Chain Analysis
  • Figure 81: Global: Dermatological Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Dermatological Drugs Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Dermatological Drugs Market Forecast: Breakup by Dermatological Diseases (in Million USD), 2026-2034
  • Table 3: Global: Dermatological Drugs Market Forecast: Breakup by Route of Administration (in Million USD), 2026-2034
  • Table 4: Global: Dermatological Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 5: Global: Dermatological Drugs Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Dermatological Drugs Market: Competitive Structure
  • Table 7: Global: Dermatological Drugs Market: Key Players